Dr. Weldon Chafe

Oncology
Office
1250 E Marshall St Ste 8-206, 
Richmond, VA 
Office
1250 E Marshall St Ste 8-206, 
Richmond, VA 

Overview

Weldon Chafe is an Oncologist practicing medicine in Richmond, Virginia.

His clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Sertoli-Leydig Cell Tumor.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 5 clinical trials.

Specialties

Oncology

Licenses

Obstetrics & Gynecology in VA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
1250 E Marshall St Ste 8-206, Richmond, VA 23298

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Unknown
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
Phase 2 Trial of Dose Dense (Weekly) Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer
Phase 2 Trial of Dose Dense (Weekly) Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drugs: Pembrolizumab, Paclitaxel
Study Phase: Phase 2
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Enrollment Status: Unknown
Publish Date: February 19, 2018
Intervention Type: Other, Behavioral
Study Phase: Phase 3
View 4 Less Clinical Trials

3 Total Publications

A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: March 28, 2017
Similar Doctors
Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

VCU Health System Stony Point

9000 Stony Point Pkwy, 
Richmond, VA 
 (7.5 miles away)
804-327-3055
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Renato Martins is an Oncologist practicing medicine in Richmond, Virginia. Dr. Martins is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Salivary Gland Tumors, and Small Cell Lung Cancer (SCLC).

Expertise in
43
conditions
Expertise in
43
conditions
Referral may be required

Virginia Commonwealth University Health System Authority

1300 E Marshall St, 
Richmond, VA 
 (0.1 miles away)
804-828-0450
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Poklepovic is an Oncologist practicing medicine in Richmond, Virginia. Dr. Poklepovic is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Melanoma, Synovial Sarcoma, Angiosarcoma, Merkel Cell Carcinoma, and Bone Marrow Aspiration.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Virginia Commonwealth University Health System Authority

1300 E Marshall St, 
Richmond, VA 
 (0.1 miles away)
804-828-4360
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Mccarty is an Oncologist practicing medicine in Richmond, Virginia. Dr. Mccarty is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.

Frequently Asked Questions about Dr. Weldon Chafe

How do I make an appointment with Dr. Weldon Chafe?

You can book an appointment with Dr. Weldon Chafe by calling their office at 804-828-4409. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Weldon Chafe a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Weldon Chafe is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Weldon Chafe specialize in?

While Dr. Weldon Chafe is a Oncology, they have specific expertise in Ovarian Cancer, Cervical Cancer, and Malignant Mixed Mullerian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Weldon Chafe participate in research or clinical trials?

Yes. Dr. Weldon Chafe has published 3 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Weldon Chafe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chafe's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile